Myriad Genetics, Inc. (MYGN) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Myriad Genetics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -1.57x | -9.76x | -6.02x | -10.44x | -78.86x | -4.22x |
| P/B Ratio | 1.56x | 1.77x | 2.02x | 1.32x | 2.22x | 0.77x |
| P/S Ratio | 0.70x | 1.48x | 2.10x | 1.72x | 3.11x | 1.32x |
| Profitability | ||||||
| Gross Margin | 69.9% | 69.9% | 68.6% | 70.2% | 71.4% | 70.9% |
| Operating Margin | -8.2% | -14.7% | -34.2% | -20.7% | -27.6% | -36.3% |
| Net Margin | -44.4% | -15.2% | -35.0% | -16.5% | -3.9% | -31.2% |
| EBITDA Margin | -40.1% | -7.1% | -26.2% | -12.5% | 1.8% | -22.0% |
| Liquidity | ||||||
| Current Ratio | 2.49x | 1.82x | 2.01x | 2.00x | 2.37x | 2.96x |
| Quick Ratio | 2.26x | 1.65x | 1.87x | 1.85x | 2.30x | 2.69x |
| Leverage | ||||||
| Debt/Equity | 0.57x | 0.20x | 0.19x | 0.16x | 0.10x | 0.21x |
YoY = year-over-year change. Source: FMP..